STOCK TITAN

Planned NBIX stock sale as Company (NASDAQ: NBIX) files Form 144

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of NBIX common stock has filed a notice of proposed sale under Rule 144, covering 36,400 common shares with an aggregate market value of $4,853,940. The shares are to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, with an approximate sale date of 01/16/2026. Common shares outstanding were 99,705,698 as of this notice.

The 36,400 shares were acquired on 01/16/2026 by exercising stock options granted by the issuer and paid for in cash. In the past three months, the seller listed as Kyle Gano previously sold 300 common shares on 11/04/2025 for gross proceeds of $42,591. By signing the notice, the seller represents that they do not know of any undisclosed material adverse information about the issuer’s operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the NBIX Form 144 filing disclose?

The filing discloses a planned Rule 144 sale of 36,400 NBIX common shares with an aggregate market value of $4,853,940, to be sold on NASDAQ through Morgan Stanley Smith Barney LLC around 01/16/2026.

How were the 36,400 NBIX shares being sold under Rule 144 acquired?

The 36,400 common shares were acquired on 01/16/2026 through an exercise of stock options from the issuer, with the exercise price paid in cash on the same date.

How many NBIX shares are outstanding in this Form 144 notice?

The notice states that the number of NBIX common shares outstanding is 99,705,698 at the time of the filing, providing context for the size of the planned sale.

What recent NBIX stock sales by the same seller are disclosed?

The filing lists that Kyle Gano sold 300 common shares on 11/04/2025 for $42,591 in gross proceeds during the past three months.

Which broker is handling the planned NBIX share sale?

The planned sale of NBIX common stock will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

What representation does the NBIX seller make in this Rule 144 notice?

By signing, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, as required under the Rule 144 notice.
Neurocrine Biosciences Inc

NASDAQ:NBIX

NBIX Rankings

NBIX Latest News

NBIX Latest SEC Filings

NBIX Stock Data

13.30B
97.85M
1.05%
102.06%
4.17%
Drug Manufacturers - Specialty & Generic
Biological Products, (no Disgnostic Substances)
Link
United States
SAN DIEGO